PIA
TMO icon

Petredis Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Petredis Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52M Sell
7,015
-8
-0.1% -$3.84K 0.24% 70
2026
Q1 		$3.45M Sell
7,023
-73
-1% -$39.6K 0.28% 70
2025
Q4 		$4.11M Sell
7,096
-91
-1% -$51.5K 0.32% 65
2025
Q3 		$3.49M Sell
7,187
-88
-1% -$41K 0.28% 66
2025
Q2 		$2.95M Buy
7,275
+76
+1% +$31.8K 0.26% 71
2025
Q1 		$3.58M Buy
7,199
+72
+1% +$39K 0.37% 56
2024
Q4 		$3.71M Sell
7,127
-168
-2% -$92.4K 0.38% 55
2024
Q3 		$4.51M Buy
7,295
+10
+0.1% +$5.92K 0.48% 46
2024
Q2 		$4.03M Sell
7,285
-13
-0.2% -$7.45K 0.45% 50
2024
Q1 		$4.24M Buy
7,298
+383
+6% +$215K 0.51% 48
2023
Q4 		$3.67M Sell
6,915
-224
-3% -$108K 0.48% 51
2023
Q3 		$3.61M Buy
7,139
+12
+0.2% +$6.39K 0.51% 49
2023
Q2 		$3.72M Sell
7,127
-27
-0.4% -$14.6K 0.51% 51
2023
Q1 		$4.12M Buy
7,154
+84
+1% +$47.3K 0.64% 44
2022
Q4 		$3.89M Buy
+7,070
New +$3.75M 0.71% 45

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Petredis Investment Advisors's TMO Position: Q2 2026 in Review

Petredis Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.11% in Q2 2026, selling an estimated $3.84K and leaving 7,015 shares worth $3.52M. The position accounts for 0.24% of the portfolio, ranked #70.

Petredis Investment Advisors first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.51M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Petredis Investment Advisors held 7,015 shares of Thermo Fisher Scientific worth $3.52M as of Q2 2026.
  • Petredis Investment Advisors sold 8 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.84K.
  • Thermo Fisher Scientific made up 0.24% of Petredis Investment Advisors's portfolio in Q2 2026, its #70 holding.
  • Petredis Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Petredis Investment Advisors's Thermo Fisher Scientific position peaked at $4.51M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Petredis Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.